Archives for September 26, 2007

← 2007

Waters and Thar collaborate for greener separations

By  Dr Matt Wilkinson

Waters and Thar Instruments have agreed to deepen their collaboration to combine their strengths in mass spectrometry (MS) and super critical fluid chromatography (SFC) to make separation science 'greener'.

Nobilon nabs adjuvant for new flu jabs

By  Anna Lewcock

Organon subsidiary Nobilon has got its hands on a promising new adjuvant that it plans to use to enhance it pandemic and seasonal flu vaccines.

GlaxoSmithKline cancer vaccine 'impressive'

By  Mike Nagle

GlaxoSmithKline (GSK) has taken a step closer to a true targeted cancer therapy, and its vaccine, which 'educates' the immune system to kill tumour cells, has showed 'impressive' results in its latest clinical trials.

Drugs moving into the clinic: 29

By  Mike Nagle

The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.

New asthma treatment gets US go-ahead

By  Anna Lewcock

An extended release formulation of an asthma treatment recently recommended by the National Asthma Education and Prevention Program has been launched on the US market.

Company Profile: Nikon Instruments

By  Dr Matt Wilkinson

LabTechnologist.com brings you an exclusive interview with Robert Forster, General Manager of Nikon UK's Instrument Division.